W81XWH22F0063↗

General Dynamics Information Technology, Inc. received this contract from W4PZ USA Med RSCH Acquis Act, Defense Health Agency: -$517.0K obligated so far for support- professional: program management/support. Its period of performance ended 2023-04-30.

Key facts · data as of Oct 23, 2026

Recipient
General Dynamics Information Technology, Inc.
Awarding agency
Defense Health Agency (Department of Defense)
Contracting office
W4PZ USA Med RSCH Acquis Act (W81XWH)
Obligated to date
-$517.0K
Potential value
$2.24M
Ends
2023-04-30

Source: USAspending.gov prime award records (obligations: money committed, not outlays), data as of Oct 23, 2026.

Cite this page: SpendQuery, Award W81XWH22F0063, data as of Oct 23, 2026, https://spendquery.com/award?id=CONT_AWD_W81XWH22F0063_9700_W81XWH22D0004_9700

FY22 BREAST CANCER RESEARCH PROGRAM

Delivery Order · Defense Health Agency · to General Dynamics Information Technology, Inc. (UEI SMNWM6HN79X5) · data as of 2026-10-23

Obligated to date-$517.0K3 actions
Current value$2.24Mwith options exercised
Period2022-05-01 → 2023-04-30current end date

What it is

Product or service
Support- Professional: Program Management/Support (PSC R408)
Industry
Professional Organizations (NAICS 813920)
Contracting office
W4PZ USA Med RSCH Acquis Act (W81XWH)
Competition
Full and open competition
Pricing
Cost plus fixed fee
How it was bought
Single-award IDIQ · under W81XWH22D0004
Solicitation
W81XWH21R0001
Where the work is
Frederick, MD · district MD-06

Obligations by fiscal year

FY2023-$517.0K

SpendQuery holds FY2023 on; earlier years are on USAspending.gov.

Subcontractors: where the money went next

No subawards reported for this award. Primes report subawards of $30,000 or more; many awards have none.

Every action

3 actions since 2023-01-18. Each is a modification or amendment with the money it added or took back.

DateModificationKindAmountWhat the agency wrote
2023-09-13P00006Funding only-$245.0KFY22 BREAST CANCER RESEARCH PROGRAM
2023-02-01P00005Funding only-$272.0KFY22 BREAST CANCER RESEARCH PROGRAM
2023-01-18P00004Supplemental agreement (work within scope)$0PER SECTION 711 OF THE 2019 NDAA, USAMRAA TRANSFERRED TO DHA 10/1/2022. FY22 BREAST CANCER RESEARCH PROGRAM

Source: USAspending.gov prime award transactions and FSRS subaward reports, as loaded by SpendQuery (data as of 2026-10-23). Amounts are obligations (money committed), not outlays. The official record on USAspending.gov ↗